Sensei Biotherapeutics
Phase 1/2Sensei Biotherapeutics follows the immune system’s teachings to discover new treatments that inspire the body to fight cancer.
Founded
2015
Focus
AntibodiesBiologicsSmall Molecules
About
Sensei Biotherapeutics follows the immune system’s teachings to discover new treatments that inspire the body to fight cancer.
Funding History
3Total raised: $211M
IPO$126MUndisclosedJan 28, 2021
Series B$50MTaiho VenturesJan 15, 2020
Series A$35MMPM CapitalJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationBoston, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile